Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan along the kynurenine pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depressive-like behaviors in rodents are mediated by an enzyme that degrades tryptophan, called indoleamine 2,3dioxygenase (IDO; O'Connor et al., 2009; see also Maes et al., 2011)”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as O'Connor et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that inflammation promotes a pattern of behavior known as sickness behavior that includes symptoms of depression, such as fatigue, anhedonia, and social withdrawal.[10,11]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, blocking glutamate receptors with ketamine or inhibiting IDO activity protects mice from LPS- or stress-induced depressive-like behaviour but leaves the inflammatory response intact85,86.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“In preclinical models, LPS-induced depressive behavior is mediated by IDO activation (O’Connor et al., 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as O’Connor et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Self-citation
Cited by
Items 501–600 of 1,001
Fu, X., Lawson, M. A., Kelley, K. W., & Dantzer, R. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-88 · Cited by 49
Self-citationLaugeray, A., Launay, J.-M., Callebert, J., Mutlu, O., Guillemin, G. J., Belzung, C., & Barone, P. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164337 · Cited by 40
Du, B., Liu, X., Zheng, H., Fan, C., Liang, M., Lian, Y., Wei, Z., Zhang, Y., & Bi, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01247 · Cited by 47
Fu, Y., Peng, Y., Huang, X., Yang, Y., Huang, L., Xi, Y., Hu, Z., Lin, S., So, K., & Ren, C. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.293156 · Cited by 49
“…including selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, act by increasing monoamines and thereby ameliorate lipopolysaccharide-induced depressive-like behavior and proinflammatory response (O’Connor et al., 2009; Ohgi et al., 2013; Yao et al., 2015).”
Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders
Morcuende, Á., García‐Gutiérrez, M. S., Tambaro, S., Nieto, E. O., Manzanares, J., & Femenía, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.866052 · Cited by 50
Postnatal programming of the innate immune response
Galic, M. A., Spencer, S. J., Mouihate, A., & Pittman, Q. J. (2009) · Integrative and Comparative Biology · doi:10.1093/icb/icp025 · Cited by 48
“…(Dantzer et al. 2008) through interactions with fundamental neurotransmitters, receptors and biosynthetic enzymes (Kent et al. 1992; Luheshi et al. 1996; Cartmell et al. 2001; Nadeau and Rivest 2001; Rivest 2001; Thibeault et al. 2001; Dunn 2006; O’Connor et al. 2009; Schafers and Sorkin 2008).”
BackgroundDiscovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review
Lazur, J., Hnatyk, K., Kała, K., Sułkowska‐Ziaja, K., & Muszyńska, B. (2023) · Antioxidants · doi:10.3390/antiox12030623 · Cited by 46
“The O’Connor team conducted a similar observation that showed that LPS administered to rodents resulted in increased kynurenine content in the brains of mice and brain tryptophan and serotonin [99].”
MethodGhosh, S., Choudhury, S., Chowdhury, O., Mukherjee, S., Das, A., Sain, A., Gupta, P., Adhikary, A., & Chattopadhyay, S. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109521 · Cited by 48
Zhang, J., Lin, W., Tang, M., Zhao, Y., Zhang, K., Wang, X., & Li, Y. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104580 · Cited by 48
Yi, S., Zou, J., Meng, L., Chen, H.-M., Hong, Z.-Q., Liu, X., Farooq, U., Chen, M.-X., Lin, Z., Zhou, W., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.864481 · Cited by 46
“It has been demonstrated that systemic low-dose administration of LPS evokes time-dependent behavior alterations and manifested sickness-like and depressive-like behaviors at 6 h and 24 h post-LPS injection (53, 54).”
BackgroundStress circuitry: mechanisms behind nervous and immune system communication that influence behavior
Tong, R. L., Kahn, U. N., Grafe, L. A., Hitti, F. L., Fried, N. T., & Corbett, B. F. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1240783 · Cited by 53
“In rodents, induction of inflammatory processes using intraperitoneal lipopolysaccharide (LPS) administration increases depressive-like behavior in mice as characterized by immobility in the forced swim test and tail suspension test (91).”
BackgroundMicroglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge
Gonzalez-Pena, D., Nixon, S. E., O’Connor, J. C., Southey, B. R., Lawson, M. A., McCusker, R. H., Borras, T., Machuca, D., Hernandez, A. G., Dantzer, R., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150858 · Cited by 41
Self-citationIida, T., Yoshikawa, T., Kárpáti, A., Matsuzawa, T., Kitano, H., Mogi, A., Harada, R., Naganuma, F., Nakamura, T., & Yanai, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.081 · Cited by 44
Agostini, A., Yuchun, D., Li, B., Kendall, D. A., & Pardon, M.-C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.09.019 · Cited by 41
“This was associated with elevated levels of degradation products of both the serotonin and nicotinamide pathways of tryptophan metabolism, suggesting their co-activation, as seen previously (Guo et al., 2016; O'Connor et al., 2009; Parrott et al., 2016).”
Casaril, A. M., Domingues, M., Bampi, S. R., Lourenço, D. D. A., Smaniotto, T. Â., Segatto, N. V., Vieira, B. M., Seixas, F. K., Collares, T. V., Lenardao, E. J., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.005 · Cited by 49
The role of immunomodulators in treatment-resistant depression: case studies
Beckett, C. W., & Niklison-Chirou, M. V. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01147-6 · Cited by 45
“It is commonly known that depression-like behaviour can be induced in animals by the injection of lipopolysaccharide (LPS), which is highly proinflammatory [4].”
BackgroundAlzarea, S. I., & Rahman, S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.05.018 · Cited by 44
“The reduction in locomotor activity is defined as sickness behavior that causes depressive-like behavior 24 h after LPS administration (O'Connor et al., 2009).”
InfluentialDesipramine decreases expression of human and murine indoleamine-2,3-dioxygenases
Brooks, A. K., Janda, T. M., Lawson, M. A., Rytych, J. L., Smith, R. A. J., Ocampo-Solis, C., & McCusker, R. H. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.010 · Cited by 42
“These data challenge the dogma that inflammation induced depression-like behaviors are solely driven by microglial Ido1-FL induction (Corona et al., 2013; O’Connor et al., 2009c).”
BackgroundInfluentialSelf-citationAl-Amin, M. M., Choudhury, M. F. R., Chowdhury, A. S., Chowdhury, T. R., Jain, P., Kazi, M., Alkholief, M. A., Alshehri, S., & Reza, H. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00384 · Cited by 46
Casaril, A. M., Domingues, M., Lourenço, D. D. A., Birmann, P. T., Padilha, N. B., Vieira, B. M., Begnini, K. R., Seixas, F. K., Collares, T. V., Lenardao, E. J., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.05.006 · Cited by 44
Wang, H., Ahmad, M., Jadayel, R., Najjar, F., Lagace, D. C., & Leenen, F. H. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217437 · Cited by 45
van den Ameele, S., van Nuijs, A. L. N., Lai, F. Y., Schuermans, J., Verkerk, R. M., van Diermen, L., Coppens, V., Fransén, E., de Boer, P., Timmers, M., et al. (2019) · Bipolar Disorders · doi:10.1111/bdi.12814 · Cited by 43
Zhao, J., Liu, X., Chang, D., Zhang, X., Lian, H., Du, X., & Gao, L. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00669 · Cited by 40
Qin, X., Shan, Q., Fang, H., Wang, Y., Chen, P., Xiong, Z., Swaab, D. F., & Zhou, J. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02371-7 · Cited by 44
Klyne, D. M., Barbe, M. F., & Hodges, P. W. (2021) · The Spine Journal · doi:10.1016/j.spinee.2021.09.006 · Cited by 45
Delgado, I., Cussotto, S., Anesi, A., Dexpert, S., Aubert, A., Aouizerate, B., Beau, C., Forestier, D., Ledaguenel, P., Magne, E., et al. (2022) · International Journal of Obesity · doi:10.1038/s41366-021-01049-0 · Cited by 42
“Whereas a large amount of data highlights the involvement of the enzyme indoleamine 2,3-dioxygenase in inflammation-driven TRP catabolism and its impact on depressive morbidity [6, 7], recent data obtained in our group indicate significant associations between systemic inflammation and the indole pathway of TRP metabo…”
BackgroundVichaya, E. G., Laumet, G. O., Christian, D. L., Grossberg, A. J., Estrada, D. J., Heijnen, C. J., Kavelaars, A., & Dantzer, R. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0075-z · Cited by 42
Self-citationAcupuncture treatment for post-stroke depression: Intestinal microbiota and its role
Jiang, H., Deng, S., Zhang, J., Chen, J., Li, B., Zhu, W., Zhang, M., Zhang, C., & Meng, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1146946 · Cited by 44
“…and kynurenine pathways), as a result, 5-HT is depleted, serotonergic transmission is blocked, as well as neuroactive tryptophan metabolites (such as kynurenine) are produced (O’Connor et al., 2009; Souza et al., 2017; Körtési et al., 2022), which eventually leading to PSD (Spalletta et al., 2006).”
Wang, T., Song, Y., Ai, Z., Liu, Y., Li, H., Xu, W., Chen, L., Zhu, G., Yang, M., & Su, D. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154852 · Cited by 43
Adeoluwa, O. A., Olayinka, J. N., Adeoluwa, G. O., Akinluyi, E. T., Adeniyi, F. R., Fafure, A. A., Nebo, K. E., Edem, E. E., Eduviere, A. T., & Abubakar, B. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114503 · Cited by 46
Mudgal, J., Mallik, S. B., Nampoothiri, M., Kinra, M., Hall, S., Grant, G. D., Anoopkumar‐Dukie, S., Davey, A. K., Rao, C. M., & Arora, D. S. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103638 · Cited by 43
“The tail suspension test (TST) was performed according to previously described methods (O’connor et al., 2009).”
MethodZhang, J., Yi, S., Li, Y., Xiao, C., Liu, C., Jiang, W., Yang, C., & Zhou, T. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05553-5 · Cited by 41
Integrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link?
Hersey, M., Hashemi, P., & Reagan, L. P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15392 · Cited by 46
Risk of clinically significant depression in HIV ‐infected patients: effect of antiretroviral drugs
Gutiérrez, F., García, L. E. G., Padilla, S., Arco, D. Á.-D., Moreno, S., Navarro, G., Gómez‐Sirvent, J., Vidal, F., Asensi, V., Masiá, M., et al. (2013) · HIV Medicine · doi:10.1111/hiv.12104 · Cited by 43
Palin, K., Bluthé, R.-M., McCusker, R. H., Levade, T., Moos, F., Dantzer, R., & Kelley, K. W. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1331-4 · Cited by 41
“This event is associated with a decrease in plasma tryptophan as a consequence of activation of indoleamine 2,3-dioxygenase that degrades tryptophan along the kynurenine pathway (O’Connor et al. 2008).”
Self-citationHuang, C., Wang, J., Lu, X., Hu, W., Wu, F., Jiang, B., Ling, Y., Yang, R., & Zhang, W. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.021 · Cited by 44
Zhu, X., Hu, J., Deng, S., Tan, Y., Qiu, C., Zhang, M., Ni, X., Lu, H., Wang, Z., Li, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.687757 · Cited by 44
The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets
Ascoli, B. M., Géa, L. P., Colombo, R., Barbé-Tuana, F. M., Kapczinski, F., & Rosa, A. R. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416642846 · Cited by 40
“For instance, systemic immune activation by LPS administration may promote neuroinflammation and depressive-like behavior in mice, and these effects seem to be attenuated by chronic antidepressant administration (O’Connor et al., 2009).”
BackgroundSuicidality and Activation of the Kynurenine Pathway of Tryptophan Metabolism
Bryleva, E. Y., & Brundin, L. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_5 · Cited by 43
Jing, W., Song, S., Sun, H., Chen, Y., Zhao, Q., Zhang, Y., Dai, G., & Ju, W. (2019) · Neural Plasticity · doi:10.1155/2019/1571392 · Cited by 43
Chan, S. Y., Probert, F., Radford‐Smith, D. E., Hebert, J. C., Claridge, T. D. W., Anthony, D. C., & Burnet, P. W. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74008-w · Cited by 42
Liu, H., Lin, Y., Tsai, M.-C., Wu, Y., & Lee, M.-C. (2022) · Antioxidants · doi:10.3390/antiox11050947 · Cited by 44
“LPS-induced depression is a specific rodent model to explore inflammation-associated behavioral responses [30,31].”
BackgroundWickens, R. A., Donck, L. V., Mackenzie, A. B., & Bailey, S. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.041 · Cited by 42
“Once the overt symptoms of sickness have subsided, depressive-like behaviours can be assessed using behavioural paradigms such as the forced swim test (FST) and the sucrose preference test (SPT), typically at 24 h after acute LPS administration (Lawson et al., 2013; O’Connor et al., 2009).”
BackgroundMethodResultInfluentialDomingues, M., Casaril, A. M., Birmann, P. T., Lourenço, D. D. A., Vieira, B. M., Begnini, K. R., Lenardao, E. J., Collares, T. V., Seixas, F. K., & Savegnago, L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00486 · Cited by 45
“During the same time that IDO is elevated, animals will present depressive-like behavioral changes including anhedonia and spend more time immobile in the FST (O’Connor et al., 2009).”
BackgroundMethodInfluentialPathophysiological mechanisms of post-myocardial infarction depression: a narrative review
Garrels, E., Kainth, T., Silva, B., Yadav, G., Gill, G., Salehi, M., & Gunturu, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1225794 · Cited by 44
“This can lead to a decrease in serotonin production and an increase in the production of kynurenine, which has been linked to the development of depression (45).”
BackgroundChawla, A., Cakmakci, D., Fiori, L. M., Zang, W., Maitra, M., Yang, J., Żurawek, D., Frosi, G., Rahimian, R., Mitsuhashi, H., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02249-4 · Cited by 45
Henry, R. J., Kerr, D. M., Finn, D. P., & Roche, M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.006 · Cited by 44
“A wealth of preclinical evidence has demonstrated that activation of TLR4 is associated with depressive-like behaviour, effects attenuated by antidepressant and anti- inflammatory agents (O'Connor et al., 2009, Wang et al., 2011, Salazar et al., 2012).”
BackgroundTufvesson‐Alm, M., Schwieler, L., Schwarcz, R. M., Goiny, M., Erhardt, S., & Engberg, G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.003 · Cited by 41
Fu, X., Jiao, J., Qin, T., Yu, J., Fu, Q., Deng, X., Ma, S., & Ma, Z. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00292-z · Cited by 39
“83 mg/kg which was chosen based on the previous reported studies (O'Connor et al. 2008; Adebesin et al. 2017; Bhattacharya et al. 2018; Walker et al. 2019).”
MethodJiang, X., Chen, Z., Yu, X., Chen, J., Sun, C., Jing, C., Xu, L., Liu, F., Ni, W., & Chen, L. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105097 · Cited by 43
Bampi, S. R., Casaril, A. M., Domingues, M., Lourenço, D. D. A., Pesarico, A. P., Vieira, B. M., Begnini, K. R., Seixas, F. K., Collares, T. V., Lenardao, E. J., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.10.003 · Cited by 40
Shimada, A., & Hasegawa‐Ishii, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00017 · Cited by 40
Melancholy, anhedonia, apathy: the search for separable behaviors and neural circuits in depression
Post, R. J., & Warden, M. R. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.02.018 · Cited by 45
Sroor, H. M., Hassan, A. M., Zenz, G., Valadez-Cosmes, P., Farzi, A., Holzer, P. D., El-Sharif, A., Gomaa, F. A. M., Kargl, J., & Reichmann, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-56859-0 · Cited by 42
Morgese, M. G., Schiavone, S., Maffione, A. B., Tucci, P., & Trabace, L. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.015 · Cited by 39
Nazzari, S., Molteni, M., Valtorta, F., Comai, S., & Frigerio, A. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.015 · Cited by 40
Vicentini, F., Szamosi, J. C., Rossi, L., Griffin, L., Nieves, K., Bihan, D. G., Lewis, I. A., Pittman, Q. J., Swain, M. G., Surette, M. G., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.03.001 · Cited by 41
“…inflammation arising from animal models of liver inflammation, arthritis, colitis, lipopolysaccharide-induced endotoxemia, and viral infections (Blank et al., 2016; D ’ Mello et al., 2013; D ’ Mello et al., 2015; Lopes et al., 2020; O ’ Connor et al., 2009; Riazi et al., 2015; Sü ß et al., 2020).”
BackgroundHöfling, C., Kulesskaya, N., Jaako, K., Peltonen, I., Männistö, P. T., Nurmi, A., Vartiainen, N. E., Morawski, M., Zharkovsky, A., Võikar, V., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.02.015 · Cited by 39
Dexamethasone Induces a Specific Form of Ramified Dysfunctional Microglia
Park, M.-J., Park, H.-S., You, M., Yoo, J., Kim, S. H., & Kwon, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1156-z · Cited by 44
Disruption of the NMDA receptor GluN2A subunit abolishes inflammation-induced depression
Francija, E., Petrovic, Z., Brkic, Z., Mitić, M., Radulović, J., & Adžić, M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.10.011 · Cited by 39
Wu, X., Chen, B., Di, Z., Jiang, S., Xu, H., Shi, M., Hu, R., Sun, S., Song, Z., Liu, J., et al. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00746-4 · Cited by 41
“01), suggesting it has a significant value as a surrogate marker of IDO activation [32, 41].”
BackgroundMethodCurrent Understanding of the Neurobiology and Longitudinal Course of Geriatric Depression
Weisenbach, S. L., & Kumar, A. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0463-y · Cited by 40
Tashiro, T., Murakami, Y., Mouri, A., Imamura, Y., Nabeshima, T., Yamamoto, Y., & Saito, K. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.09.050 · Cited by 40
Barone, P. R. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000477 · Cited by 39
Prospective study of the effects of sport-related concussion on serum kynurenine pathway metabolites
Meier, T. B., Nitta, M. E., Teague, T. K., Nelson, L. D., McCrea, M., & Savitz, J. B. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.002 · Cited by 38
Hebert, J. C., Radford‐Smith, D. E., Probert, F., Ilott, N. E., Chan, K. W., Anthony, D. C., & Burnet, P. W. J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.034 · Cited by 38
Fronza, M. G., Baldinotti, R., Fetter, J., Rosa, S. G., Sacramento, M., Nogueira, C. W., Alves, D. A. C., Praticò, D., & Savegnago, L. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.002 · Cited by 42
Gong, S., & Deng, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1053136 · Cited by 51
“LPS promotes the activation of microglia and induces depressive-like symptoms, while treatment with antiinflammatory medication alleviates depressive symptoms (92, 93).”
BackgroundOenothein B Suppresses Lipopolysaccharide (LPS)-Induced Inflammation in the Mouse Brain
Okuyama, S., Makihata, N., Yoshimura, M., Amakura, Y., Yoshida, T., Nakajima, M., & Furukawa, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059767 · Cited by 41
“Anyhow, peripherally injected LPS has the ability to induce immune responses in the brain, resulting in depression-like behavior [22] or mnesic deficits [23,24].”
BackgroundPalin, K., McCusker, R. H., Strle, K., Moos, F., Dantzer, R., & Kelley, K. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1086-y · Cited by 40
Self-citationRepeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice
Larsson, M. K., Faka, A., Bhat, M., Imbeault, S., Goiny, M., Orhan, F., Oliveros, A., Ståhl, S., Liu, X. C., Choi, D., et al. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1939-4 · Cited by 41
Ohm, M., Hosseini, S., Lonnemann, N., He, W., More, T. H., Goldmann, O., Medina, E., Hiller, K., & Körte, M. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03188-3 · Cited by 39
“Additionally, neuroinflammation has been linked to the progression of various neuropathological conditions, including neuro-degenerative diseases like Alzheimer’s disease (AD) [14, 15, 59–61].”
BackgroundGuard, B. C., & Suchodolski, J. S. (2016) · Journal of Animal Science · doi:10.2527/jas.2015-0029 · Cited by 45
Vichaya, E. G., Vermeer, D. W., Christian, D. L., Molkentine, J. M., Mason, K. A., Lee, J. H., & Dantzer, R. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.02.006 · Cited by 36
Self-citationWang, Y., Jiang, H., Meng, H., Lü, J., Li, J., Zhang, X., Yang, X., Zhao, B., Sun, Y., & Bao, T. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.07.021 · Cited by 38
Glial mechanisms underlying major depressive disorder: Potential therapeutic opportunities
Rahman, S., & Alzarea, S. I. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.010 · Cited by 38
Millischer, V., Heinzl, M. W., Faka, A., Resl, M., Trepci, A., Klammer, C., Egger, M., Dieplinger, B., Clodi, M., & Schwieler, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02196-x · Cited by 36
“For example, treatment with LPS induces IDO1 expression [43, 44] along with sickness behavior [42], depression-like behavior [44], and cognitive deficits [45–47].”
BackgroundAkkermansia muciniphila ameliorates depressive disorders in a murine alcohol-LPS (mALPS) model
Guo, D., Park, C., Li, Y., Li, B., Yang, Q., Deng, Y., Gao, N., Li, R., Wang, X., Yi, L., et al. (2022) · Food & Function · doi:10.1039/d2fo01478e · Cited by 38
The fiery landscape of depression: A review of the inflammatory hypothesis
Hashmi, A. M., Aftab, A., Mazhar, N., Umair, M., & Butt, Z. (2013) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.293.3357 · Cited by 40
Affective functioning after delirium in elderly hip fracture patients
Slor, C. J., Witlox, J., Jansen, R. W. M. M., Adamis, D., Meagher, D. J., Tieken, E., Houdijk, A. P. J., van Gool, W. A., Eikelenboom, P., & de Jonghe, J. F. M. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212001962 · Cited by 36
Koshiguchi, M., Komazaki, H., Hirai, S., & Egashira, Y. (2017) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1274636 · Cited by 37
Numata, S., Iga, J., Nakataki, M., Tayoshi, S., Taniguchi, K., Sumitani, S., Tomotake, M., Tanahashi, T., Itakura, M., Kamegaya, Y., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30852 · Cited by 38
Gut Microbiota Regulation of AHR Signaling in Liver Disease
Wang, B., Zhou, Z., & Li, L. (2022) · Biomolecules · doi:10.3390/biom12091244 · Cited by 39
Dar, W. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112295 · Cited by 36
Okusaga, O. O., Duncan, E., LANGENBERG, P. W., Brundin, L., Fuchs, D., Groer, M. E., Giegling, I., Stearns‐Yoder, K. A., Hartmann, A. M., Konte, B., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.10.002 · Cited by 37
Mahmoud, M. E., Fereig, R. M., & Nishikawa, Y. (2017) · Infection and Immunity · doi:10.1128/iai.00007-17 · Cited by 36
“For example, mice exhibited sickness symptoms in the form of reduced body weight and locomotor activity and depressive symptoms such as a reduced preference for sucrose and lower motility in forced-swim and tail suspension tests (8, 9).”
BackgroundInfluentialLam, C. S., Li, J.-J., Tipoe, G. L., Youdim, M. B. H., & Fung, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177940 · Cited by 36
Wang, K., Li, F., Cui, Y., Cui, C., Cao, Z., Xu, K., Han, S., Zhu, P., & Sun, Y. S. (2019) · Mediators of Inflammation · doi:10.1155/2019/2987901 · Cited by 43
“Some preclinical studies also had consistent findings that supported the hypothesis that IFN-γ is a crucial mediator in the pathogenesis of depression [19].”
ResultSCI and depression: Does inflammation commandeer the brain?
Brakel, K., & Hook, M. A. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.112977 · Cited by 36
Couch, Y., Xie, Q., Lundberg, L., Sharp, T., & Anthony, D. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130643 · Cited by 41
“The IDO theory postulates that pro-inflammatory cytokines up-regulate the activity of IDO and therefore deplete the levels of tryptophan available for making 5-HT [36].”
BackgroundWang, D., Lin, W., Pan, Y., KUANG, X.-Y., Qi, X., & Sun, H. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.011 · Cited by 36
Anti-inflammatory effects of minocycline are mediated by retinoid signaling
Clemens, V., Regen, F., Bret, N. L., Heuser, I., & Hellmann‐Regen, J. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0460-x · Cited by 37
Carabelli, B., Delattre, A. M., Waltrick, A. P. F., Araújo, G., Suchecki, D., Machado, R. B., de Souza, L. E. R., Zanata, S. M., Zanoveli, J. M., & Ferraz, A. C. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112675 · Cited by 37
Birmann, P. T., Casaril, A. M., Pesarico, A. P., Caballero, P. S., Smaniotto, T. Â., Rodrigues, R. R., Moreira, Â. N., Conceição, F. R., Sousa, F. S. S., Collares, T. V., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105740 · Cited by 36
Gong, Q., Li, W., Ali, T., Hu, Y., Mou, S., Liu, Z., Zheng, C., Gao, R., Li, A., Li, T., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02646-5 · Cited by 34
“rescued depressive-like behaviors and prevented neuroin fl ammation LPS is widely used as a depression agent via neuroin fl ammatory inducer [31, 32].”
MethodResultAntunes, M. S., Ruff, J. R., Janner, D. E., Piêgas, M. B., de Brito, M. L. O., Rocha, K. M. A., de Gomes, M. G., Goes, A. T. R., Souza, L. C., Donato, F., et al. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.05.018 · Cited by 34
Lebeña, A., Vegas, Ó., Gómez-Lázaro, E., Arregi, A., Garmendia, L., Beitia, G., & Azpiroz, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.045 · Cited by 34
Gurbani, S. S., Yoon, Y., Weinberg, B. D., Salgado, E., Press, R. H., Cordova, J. S., Ramesh, K. K., Liang, Z., Vega, J. E. V., Voloschin, A. D., et al. (2019) · Tomography · doi:10.18383/j.tom.2018.00031 · Cited by 35
“For the tail suspension test, the lipopolysaccharide (LPS)-induced depression model was used (17).”
MethodHemmati, S., Sadeghi, M. A., Jafari, R. M., Yousefi‐Manesh, H., & Dehpour, A. R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1509-1 · Cited by 36
Cathomas, F., Fuertig, R., Sigrist, H., Newman, G. N., Hoop, V., Bizzozzero, M., Mueller, A., Luippold, A., Ceci, A., Hengerer, B., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.184 · Cited by 33
Metadata
- Authors
- O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dantzer, R
- Venue
- Molecular Psychiatry
- Published
- 2008-01-15
- Volume
- 14
- Issue
- 5
- Pages
- 511-522
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2683474
- OpenAlex
- W2050508296
- Cited by
- 1,278
- References
- 56
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 82 · 2023: 86 · 2022: 94 · 2021: 106 · 2020: 88 · 2019: 86 · 2018: 95 · 2017: 87 · 2016: 88 · 2015: 76 · 2014: 61 · 2013: 71 · 2012: 38
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029573)
- National Institute of Mental Health (R01MH079829, R01MH071349, R01 MH-71349)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK059802, T32 DK59802-01)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, depression-like behavior, kynurenine pathway, tryptophan catabolism, minocycline, 1-methyltryptophan, L-kynurenine, kynurenine/tryptophan ratio, serotonin turnover, inflammatory cytokines, comorbid depression
- MeSH terms
- Animals, Behavior, Animal, Chromatography, High Pressure Liquid, Cytokinins, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Kynurenine, Lipopolysaccharides, Male, Mice, Inbred ICR, Minocycline, Motor Activity, Swimming, Time Factors, Tryptophan, Hindlimb Suspension, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.